Please login to the form below

Not currently logged in
Email:
Password:

peginterferon beta-1a

This page shows the latest peginterferon beta-1a news and features for those working in and with pharma, biotech and healthcare.

Biogen and AbbVie bag FDA approval for multiple sclerosis drug

Biogen and AbbVie bag FDA approval for multiple sclerosis drug

patients by 45% when compared with Avonex (peginterferon beta-1a) at week 144. ... The new approval adds to Biogen's already sizeable stable of MS drugs on the market, which include Avonex and its long-acting version Plegridy (peginterferon beta-1a), and

Latest news

More from news
Approximately 2 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health
For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...

Infographics